

Can't find Vaxchora before your trip? Learn about cholera vaccine alternatives, other protective measures, and what to do if Vaxchora is unavailable.
Your doctor recommended the cholera vaccine before your international trip, but you can't find Vaxchora anywhere near you. Now what?
This is a frustrating but surprisingly common situation. Vaxchora is the only FDA-approved cholera vaccine in the United States, and because of limited demand and specialty storage requirements, many pharmacies don't carry it. If your travel date is approaching and you still haven't been able to locate the vaccine, here's what you need to know about your options.
Vaxchora is the brand name for Vibrio Cholerae Cvd 103-Hgr Strain Live Antigen, a live, attenuated oral cholera vaccine made by Emergent Travel Health Inc. It's approved for people ages 2 through 64 who are traveling to cholera-affected areas.
The vaccine is taken as a single oral dose — a liquid you drink — at least 10 days before potential cholera exposure. It doesn't require an injection and can be administered at a travel health clinic, hospital, or pharmacy equipped to handle medical waste.
Vaxchora contains a weakened (attenuated) strain of Vibrio cholerae that has been genetically modified so it cannot produce active cholera toxin. When you drink the vaccine, the weakened bacteria colonize your gut and trigger your immune system to produce protective antibodies — without causing cholera disease.
In clinical challenge studies, Vaxchora demonstrated:
It's a highly effective vaccine, which is why finding an alternative isn't straightforward.
While Vaxchora is the only option available in the US, other cholera vaccines exist globally. Here's what's out there:
Dukoral is an inactivated (killed) oral cholera vaccine that combines whole cells of V. cholerae O1 with recombinant cholera toxin B subunit. It requires two doses taken 1-6 weeks apart, with a booster after 2 years for ongoing protection.
If you're traveling through or stopping in Canada, Europe, or Australia before reaching your final destination, you may be able to receive Dukoral abroad. Discuss this option with your travel medicine provider.
Shanchol is a bivalent inactivated oral cholera vaccine that covers both V. cholerae O1 and O139 serogroups. It also requires two doses given 2 weeks apart.
Euvichol-Plus is essentially equivalent to Shanchol — a bivalent inactivated oral cholera vaccine produced in South Korea. It's the most widely used vaccine in WHO's global cholera vaccine stockpile, with over 150 million doses distributed worldwide.
If you cannot find Vaxchora in the US and won't be passing through a country where another cholera vaccine is available, focus on prevention through hygiene and food safety:
These precautions significantly reduce your risk even without vaccination. Cholera is transmitted through contaminated water and food, so careful hygiene is your strongest defense.
Before resigning yourself to traveling without the vaccine, try these additional steps:
For a complete guide, see our article on how to find Vaxchora in stock near you.
Vaxchora is the only FDA-approved cholera vaccine in the United States, and there is no true domestic substitute. Other cholera vaccines exist internationally but are not licensed here. If you can't find Vaxchora before your trip, talk to your travel medicine provider about prevention strategies and whether you might access a vaccine at your destination or during a layover.
Planning ahead is the best way to avoid this situation. Start looking for Vaxchora as soon as you book your trip, and use tools like Medfinder to streamline your search.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.